Han C. Kang

Puch'on, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications

Cross-species metabolic characterization of eutylone and mechanism-based inhibition of CYP2D6 and CYP2B6 with drug interaction implications.

Cross-species metabolic characterization of eutylone and mechanism-based inhibition of CYP2D6 and CYP2B6 with drug interaction implications.

Journal: Scientific reports
Published: February 06, 2026

Nanostructured branched Y-DNA promotes antitumor immunity through dual activation of cGAS/STING and TLR9.

Nanostructured branched Y-DNA promotes antitumor immunity through dual activation of cGAS/STING and TLR9.

Journal: Archives of pharmacal research
Published: November 26, 2025

Metabolite phenotyping of kobusin and identification of glutathione conjugates with kobusin catechol metabolite.

Metabolite phenotyping of kobusin and identification of glutathione conjugates with kobusin catechol metabolite.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 03, 2025

RSK2 and its binding partners: an emerging signaling node in cancers.

RSK2 and its binding partners: an emerging signaling node in cancers.

Journal: Archives of pharmacal research
Published: March 09, 2025

Karyoptosis as a novel type of UVB-induced regulated cell death.

Karyoptosis as a novel type of UVB-induced regulated cell death.

Journal: Free radical research
Published: December 03, 2024

RSK2-mediated cGAS phosphorylation induces cGAS chromatin-incorporation-mediated cell transformation and cancer cell colony growth.

RSK2-mediated cGAS phosphorylation induces cGAS chromatin-incorporation-mediated cell transformation and cancer cell colony growth.

Journal: Cell death discovery
Published: July 28, 2024

Hepatocyte-specific RIG-I loss attenuates metabolic dysfunction-associated steatotic liver disease in mice via changes in mitochondrial respiration and metabolite profiles.

Hepatocyte-specific RIG-I loss attenuates metabolic dysfunction-associated steatotic liver disease in mice via changes in mitochondrial respiration and metabolite profiles.

Journal: Toxicological research
Published: June 21, 2024

SPOP-mediated RIPK3 destabilization desensitizes LPS/sMAC/zVAD-induced necroptotic cell death.

SPOP-mediated RIPK3 destabilization desensitizes LPS/sMAC/zVAD-induced necroptotic cell death.

Journal: Cellular and molecular life sciences : CMLS
Published: June 20, 2024

Beyond nanoparticle-based oral drug delivery: transporter-mediated absorption and disease targeting.

Beyond nanoparticle-based oral drug delivery: transporter-mediated absorption and disease targeting.

Journal: Biomaterials science
Published: May 07, 2024

Selective delivery of imaging probes and therapeutics to the endoplasmic reticulum or Golgi apparatus: Current strategies and beyond.

Selective delivery of imaging probes and therapeutics to the endoplasmic reticulum or Golgi apparatus: Current strategies and beyond.

Journal: Advanced drug delivery reviews
Published: May 01, 2024

ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance.

ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance.

Journal: Cell death & disease
Published: January 05, 2024

Beyond Nanoparticle-Based Intracellular Drug Delivery: Cytosol/Organelle-Targeted Drug Release and Therapeutic Synergism.

Beyond Nanoparticle-Based Intracellular Drug Delivery: Cytosol/Organelle-Targeted Drug Release and Therapeutic Synergism.

Journal: Macromolecular bioscience
Published: December 28, 2023
Showing 1-12 of 94

Last Updated: 09/26/2026